At the end of the latest market close, Predictive Oncology Inc. (POAI) was valued at $1.51. In that particular session, Stock kicked-off at the price of $1.58 while reaching the peak value of $1.58 and lowest value recorded on the day was $1.41. The stock current value is $1.35.
Recently in News on June 2, 2021, Predictive Oncology Inc. to Attend BIO DIGITAL, the World’s Largest Biotech Partnering Experience. Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, announced today that its three wholly owned subsidiaries, Helomics, TumorGenesis and Soluble Biotech, will be attending BIO DIGITAL, a key international biotech partnering event held virtually on June 10-11 & 14-18, 2021. You can read further details here
Predictive Oncology Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $2.3000 on 02/17/21, with the lowest value was $0.7100 for the same time period, recorded on 01/08/21.
Predictive Oncology Inc. (POAI) full year performance was -15.17%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Predictive Oncology Inc. shares are logging -41.45% during the 52-week period from high price, and 113.76% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.63 and $2.30.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1891282 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Predictive Oncology Inc. (POAI) recorded performance in the market was 106.17%, having the revenues showcasing -13.71% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 67.90M, as it employees total of 22 workers.
Predictive Oncology Inc. (POAI) in the eye of market guru’s
During the last month, 0 analysts gave the Predictive Oncology Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.3202, with a change in the price was noted +0.30. In a similar fashion, Predictive Oncology Inc. posted a movement of +28.87% for the period of last 100 days, recording 3,660,127 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for POAI is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Predictive Oncology Inc. (POAI): Stocks Technical analysis and Trends
Raw Stochastic average of Predictive Oncology Inc. in the period of last 50 days is set at 64.73%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 63.88%. In the last 20 days, the company’s Stochastic %K was 78.94% and its Stochastic %D was recorded 85.53%.
If we look into the earlier routines of Predictive Oncology Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 106.17%. Additionally, trading for the stock in the period of the last six months notably improved by 116.61%, alongside a downfall of -15.17% for the period of the last 12 months. The shares increased approximately by 7.86% in the 7-day charts and went down by 58.05% in the period of the last 30 days. Common stock shares were lifted by -13.71% during last recorded quarter.